Lipocalin-2 (LCN2), also known as neutrophil gelatinase-associated lipocalin (NGAL), is released by innate immune cells and can serve as an attractive biomarker of inflammation, ischemia, infection, and kidney damage. Here, LCN2 is linked to ischemia.